How would you characterize your basic research area?
It’s in the general area of food chemistry, looking at
naturally occurring toxicants and naturally occurring health
protectants, namely isoflavone content in commercial soybean foods.
When I started my work here at Iowa State many years ago, these
isoflavones—which are now being cited in a lot of articles—were
considered toxicants because of their estrogen activity. It was at
the same time that DES (diethystilbesterol) was removed from use in
beef cattle as a growth stimulant because of the concerns about DES
residues in beef. In the late 1970s and early 1980s these
phytoestrogens in soy were
considered toxic constituents. By 1990,
everything had turned around and now they were considered good guys
or health-protective agents through probably the same estrogen
mechanism and others.
Interest in natural toxicants and health protectants has been a
fluid field. With compounds that were once considered toxic, now
cross out "toxic" and put in "health-protective
agent." The attention this area now receives has been great
because it’s opened up a whole new approach where these compounds
are now considered very important health protective agents.
We’ve looked at other components in soy that also may have
health-protective effects. That includes soy proteins and a new
compound called soy saponins. They’re another phytochemical
associated with soy proteins. Saponins are ethanol extractable like
isoflavones, so they’re in many nutraceutical products that are
marketed as phytoestrogens.
We’re interested in looking at the less famous compounds in soy
foods because we think that they also have health-protective
effects. There are many components in soy that may be
health-beneficial and working together gives the overall good health
picture for soy. That’s why we see people who eat whole soy
protein having a better health status than people who maybe just
select to eat an isoflavone extract. You don’t see the lowering of
plasma cholesterol when people take isoflavone extract as tablets,
but if they eat soy protein with its associated natural non-protein
components we do see cholesterol lower.
For about 20 years. In the old days when you came to a department
your chairman said, "You’re going to work in this area."
I was interested in looking for some compounds with which I could
learn to use HPLC technology, which was new when I was a beginning
professor, and working with the non-protein components associated
with soy fit the bill. Isoflavones were a way to learn that
technology and it’s just expanded since then.
I’ve seen the field go back and forth. Now there’s a concern
that there may be some toxic effects for certain population groups
versus health-protective effects for probably most individuals. Some
groups want to label soy phytoestrogens as endocrine disrupters;
however, the evidence is not persuasive. Data on individuals who
consumed soy-based infant formula and who are now in their 30s and
40s show no differences from the norm. There is considerable data
that the phytoestrogens may protect against certain cancers if
individuals are exposed to them during early life. The Chinese have
been consuming these compounds as part of their diet for more than
2000 years and we do not see problems.
I think I’ve been fortunate to be working in a field that went
pretty much unnoticed for a decade and then suddenly—and you’re
still working there—everyone notices by chance or serendipity what
you’ve been doing.
What have been some of the greatest challenges in performing
your work?
I always think the biggest challenge for people at universities
is getting funding to support their work and graduate students. In
the last 20 years it’s really changed in my field. In about 1990,
the National Institutes of Health really got interested in diet for
promoting good health. Prior to that there was not that much of a
concern for this particular approach. There was more of a focus on
what to do after the disease has occurred. Post-1990, NIH embraced a
philosophy that included looking at what we can do to prevent
diseases before they occur, and this is where food and nutrition
have found more room for getting grants from NIH, which is certainly
the major government agency to do health-related research. Because
of that interest, it has spurred this whole area of soy in
particular, but also all kinds of different work with food and food
components and how they affect health.
How rapidly has the state of knowledge in your field evolved in
the last decade and what were some of the key discoveries that
furthered that advancement?
Food scientists are typically generalists. We know a lot about
many sciences, but less depth in particular areas. However, we
interface with people in chemical engineering, nutrition, chemistry,
and biochemistry. It’s that ability to form interfaces that’s
critical for this knowledge to go forward. One of the positive
aspects that’s evolved in the soy health field over the years is
an understanding by the clinician community that soy is not just a
black box. There are a variety of components in it, and the soy
products that the food industry produces are not all the same.
Another area that we’re learning more about is the differences
in individuals in their ability to adjust and absorb phytochemicals
from foods due to differing microbial populations among individuals.
We have observed different bioavailability groups for the soy
isoflavones. Some individuals are fast isoflavone degraders in their
gut and hence are low isoflavone absorbers into their plasma. Other
individuals are slow isoflavone degraders in the gut, so have higher
bioavailability of the isoflavones and therefore absorb more into
their plasma. These data are probably the result of several factors,
including differences in the microorganisms in the gut and genetics
and diet that govern gut transit time. The longer the food stays in
the gut, the better chance it has to be absorbed, if it is not first
degraded by the gut microbes. What this all means is that we may be
able to change how people absorb phytochemicals by learning the
combination of diet, genetics, and physiology that works best.
What is the implication of your work for the future of your
field and allied fields?
We’re headed in the direction of just understanding these
components and how we can design processes to make foods that either
enhance components, make higher concentrations in products where we
want them, or lower concentrations where we want them. And we want
to also design specialty products to help us understand the health
effects of soy components. Our ability to make soy products with
specific amounts of soy protein and/or isoflavones and/or saponins
and/or other phytochemicals can be used for research, and if shown
to be efficacious can be developed for consumers.
Where do you predict the state of knowledge in your
field will be in 10 years?
I think we’re going to learn ways to enhance people’s ability
to absorb these compounds so that they’ll have the health effects
that we think they do. We’re going to understand the variations
among individuals in their ability to absorb probiotic products to
change microbial flora in the gut so you’ll absorb what you want
or not absorb what you don’t want.
I think we’ll also see a larger use of soy and other vegetable
products in the US and in the world as people try to make healthier
choices in what they eat. And I think the technology in our ability
to identify what's in products is going to improve. Microrarray
technologies are going to come about to supplant some of the
conventional wet chemistry we use. That will allow us to do many
more analyses per unit time. Right now it takes one hour to do an
analytical analysis of one isoflavone sample, and we can only run
one at a time on our HPLC. If we can design technologies to give us
multiple tests at once, our efficiency will be improved. I think the
bioinformatics revolution is going to speed up our understanding of
what’s going on.
What advice would you give to those entering a research
career in general?
I recommend if they haven’t tried doing any research as an
undergrad they should find a professor that they can work for and
try doing research. That’s a great way to find out if you’re
suited for this type of career. I also suggest that students try not
to close any doors. Take as many of those tough courses that you may
want to avoid, but take them because that could allow you many
options.
What would you like the general public to understand
about your work?
I hope that they will begin to understand how to make
judgments about what’s in their food and to make good judgments
based on knowledge, not on irrationality. And to understand that to
have a good food supply there are a variety of different foods as
well as nutraceuticals out there with health protective compounds.
We know a lot about foods and can make good recommendations. We know
very little about the long-term effects of nutraceutical products
and want the public to use caution. There’s no substitute for
grandma’s advice of eating lots of different things in moderation
and nothing to excess. That statement still applies today in how we
make choices about what we eat.
Patricia Murphy, Ph.D.
Iowa State University
Department of Food Science and Human Nutrition
Ames, IA, USA